Literature DB >> 19665383

Dexamethasone for intracranial neurosurgery and anaesthesia.

Brad Hockey1, Kate Leslie, Daryl Williams.   

Abstract

Dexamethasone is frequently administered to patients with brain tumours having neurosurgery, and is often given for other purposes by anaesthetists. This review outlines the rationale for its use by both specialities, and discusses its potential adverse effects.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19665383     DOI： 10.1016/j.jocn.2009.03.007

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN： 0967-5868            Impact factor:   1.961


  11 in total

1.  Evaluation of hyperglycaemic response to intra-operative dexamethasone administration in patients undergoing elective intracranial surgery: A randomised, prospective study.

Authors:  Rakesh Sethi; Imtiaz A Naqash; Sukhminder Jit Singh Bajwa; Vikas Dutta; Altaf Umar Ramzan; Syed Amir Zahoor
Journal:  Asian J Neurosurg       Date:  2016 Apr-Jun

Review 2.  Potential of Glioblastoma-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy.

Authors:  Ryan D Salinas; Joseph S Durgin; Donald M O'Rourke
Journal:  CNS Drugs       Date:  2020-02       Impact factor: 5.749

3.  Preoperative assessment of adult patients for intracranial surgery.

Authors:  Vanitha Sivanaser; Pirjo Manninen
Journal:  Anesthesiol Res Pract       Date:  2010-03-31

Review 4.  Analgesic use in nonhuman primates undergoing neurosurgical procedures.

Authors:  Louis DiVincenti
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-01       Impact factor: 1.232

5.  Cerebellar mutism syndrome in children with brain tumours of the posterior fossa.

Authors:  Morten Wibroe; Johan Cappelen; Charlotte Castor; Niels Clausen; Pernilla Grillner; Thora Gudrunardottir; Ramneek Gupta; Bengt Gustavsson; Mats Heyman; Stefan Holm; Atte Karppinen; Camilla Klausen; Tuula Lönnqvist; René Mathiasen; Pelle Nilsson; Karsten Nysom; Karin Persson; Olof Rask; Kjeld Schmiegelow; Astrid Sehested; Harald Thomassen; Ingrid Tonning-Olsson; Barbara Zetterqvist; Marianne Juhler
Journal:  BMC Cancer       Date:  2017-06-21       Impact factor: 4.430

6.  Mineralocorticoid receptor status in the human brain after dexamethasone treatment: a single case study.

Authors:  Anne-Sophie C A M Koning; Philippe C Habets; Marit Bogaards; Jan Kroon; Hanneke M van Santen; Judith M de Bont; Onno C Meijer
Journal:  Endocr Connect       Date:  2022-03-14       Impact factor: 3.335

7.  Peri-operative dexamethasone therapy and post-operative psychosis in patients undergoing major oral and maxillofacial surgery.

Authors:  Chethan Manohara Koteswara; Pritish Patnaik
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2014-01

8.  Treatment with the NK1 antagonist emend reduces blood brain barrier dysfunction and edema formation in an experimental model of brain tumors.

Authors:  Elizabeth Harford-Wright; Kate M Lewis; Mounir N Ghabriel; Robert Vink
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

9.  A single high dose of dexamethasone affects the phosphorylation state of glutamate AMPA receptors in the human limbic system.

Authors:  M W Lopes; R B Leal; R Guarnieri; M L Schwarzbold; A Hoeller; A P Diaz; G L Boos; K Lin; M N Linhares; J C Nunes; J Quevedo; Z A Bortolotto; H J Markowitsch; S L Lightman; R Walz
Journal:  Transl Psychiatry       Date:  2016-12-13       Impact factor: 6.222

Review 10.  Pediatric Low-Grade Gliomas.

Authors:  Kelly L Collins; Ian F Pollack
Journal:  Cancers (Basel)       Date:  2020-05-04       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.